San Francisco, California
Colorectal cancer clinical trials in San Francisco, CA
29 colorectal cancer studies are recruiting participants at sites in San Francisco as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Francisco at a glance
- 29 studies are recruiting at a site in San Francisco.
- By phase: Phase 1 (8), Phase 1/2 (8), Phase 2 (1), Phase 2/3 (2), Phase 3 (3), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (21), university, hospital or other (8).
- Most recent update to one of these records: November 5, 2026.
Studies recruiting in San Francisco
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Study site
- UCSF Mount Zion Medical Ctr
- Registry record
- NCT07549412 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- California Pacific Medical Center-Pacific Campus · Kaiser Permanente-San Francisco
- Registry record
- NCT05174169 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Kaiser Permanente-San Francisco
- Registry record
- NCT06418204 · updated
Distance-Based Exercise to Preserve Function and Prevent Disability
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Kaiser Permanente-San Francisco
- Registry record
- NCT07059884 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07397338 · updated
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Study site
- University of California, San Francisco
- Registry record
- NCT07584226 · updated
LYL273 for Patients With Relapsed or Refractory mCRC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- University of California San Francisco Medical Center
- Registry record
- NCT05319314 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- California Pacific Medical Center - Pacific Campus
- Registry record
- NCT07221357 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT05786924 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- UCSF Medical Center · UCSF at China Basin · UCSF at Mount Zion
- Registry record
- NCT07222800 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT05919264 · updated
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EvolveImmune United, Inc
- Study site
- UCSF Medical center Parnassus
- Registry record
- NCT07217171 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT03715933 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Registry record
- NCT07321106 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- UCSF Medical Center-Mission Bay
- Registry record
- NCT04851119 · updated
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of California, San Francisco
- Study site
- University of California, San Francisco
- Registry record
- NCT04221893 · updated
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ArriVent BioPharma, Inc.
- Registry record
- NCT07066657 · updated
A Study of DM002 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Study site
- University of California San Francisco Cancer Center
- Registry record
- NCT06751329 · updated
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT06917079 · updated
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- University of California, San Francisco
- Registry record
- NCT05663502 · updated
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Stanford University
- Study sites
- Kaiser Foundation Research Institute · University of San Francisco · Zuckerberg San Francisco General
- Registry record
- NCT05297734 · updated
A Study of MGC028 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study site
- UCSF - Helen Diller Family Cancer Center
- Registry record
- NCT06723236 · updated
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- MBrace Therapeutics
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07145255 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- University of California San Francisco
- Registry record
- NCT06778863 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
A Study of NX-1607 in Adults With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- University of California, San Francisco
- Registry record
- NCT05107674 · updated
A Multicenter Cancer Biospecimen Collection Study
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Cofactor Genomics, Inc.
- Study site
- Curebase
- Registry record
- NCT04510129 · updated
A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT06281678 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.
Ask about studies near San Francisco
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
193 studies recruiting across 110 cities.
Los Angeles
92 studies recruiting.
Duarte
50 studies recruiting.
Orange
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections